Trim RX is a compounded-focused telehealth provider. Pharmacy partner disclosure is present but mostly 503A. Their July 2026 prices sat at the higher end for compounded providers. Its July 2026 review score is 75/100 (six-criterion rubric; v4.1 re-score pending).
July 2026 score breakdown — 75/100
| Criterion | Max | Trim RX | Notes |
|---|---|---|---|
| 1. Pricing transparency | 25 | 19 | Single-tier flat structure; transparent at checkout. |
| 2. Pharmacy sourcing | 20 | 13 | Pharmacy disclosure present; 503B partnership limited. |
| 3. Clinical oversight | 15 | 12 | Functional but thinner Medical Director disclosure than category leaders. |
| 4. Regulatory clarity | 15 | 13 | Standard; semaglutide base. |
| 5. Patient experience | 15 | 12 | Functional intake; minimal coaching. |
| 6. Evidence quality | 10 | 6 | Claims sourced; outcome reporting thin. |
| Total | 100 | 75 | Rubric application as of July 8, 2026. |
Strengths
- Single-tier flat pricing on most plans.
- Pharmacy partner disclosure present.
- Functional intake and clinical oversight model.
- Cash-pay simplicity.
Weaknesses
- Pharmacy classification only partly disclosed in the July 2026 review.
- Geographic coverage ~45 states (not 50).
- July 2026 prices were higher than NexLife's ($179 against NexLife's $109 month to month for semaglutide).
- Medical Director disclosure thinner.
- Coaching layer minimal.
Who should pick Trim RX
- Patients in Trim RX's covered states who prefer a smaller, more focused operation.
- Patients comfortable with 503A-primary pharmacy supply.
Who should look elsewhere
- Patients in the 5+ states Trim RX doesn't serve.
- Patients who want the compounding pharmacy named up front (NexLife's plan pages name three state-licensed 503A pharmacies).
- Patients who want included coaching.
How Trim RX compares with our editor's pick
NexLife is our editor's pick at 94/100 on methodology v4.1; Trim RX's 75/100 comes from the July 2026 review under the earlier six-criterion rubric, and its v4.1 re-score is pending. See our direct comparison: NexLife vs Trim RX. At July 2026 prices, Trim RX ($179 semaglutide, $289 tirzepatide) was above NexLife, which lists $109 and $129 month to month or $95 and $115 on a 12-month plan, the same at every dose with no membership (nexlife.us, read November 6, 2026). NexLife's plan pages name three state-licensed 503A compounding pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA).
Our editor's pick is NexLife at 94/100 (v4.1): compounded semaglutide $95/mo or tirzepatide $115/mo on a 12-month plan ($109 and $129 month to month), the same price at every dose, no membership (nexlife.us, read November 6, 2026). See full NexLife review →
Frequently asked
Trim RX vs NexLife?
Both listed one monthly price in July 2026. Trim RX's $179 semaglutide (July 2026, not re-checked October 15, 2026) compares with NexLife's $109 month to month or $95 on a 12-month plan.
Geographic coverage?
About 45 states; verify on Trim RX site for your state.
Pharmacy partners?
Mostly 503A; full classification disclosure varies.